Pharmaceutical Diagnostics

Overview

Support

Overview

Support

A global leader

Our products are used around the world, enhancing imaging procedures to enable better patient outcomes

Pharmaceutical Diagnostics

We are a leading supplier of contrast media and radiopharmaceutical imaging agents for medical imaging examinations. Our products help healthcare professionals in 130 + countries to diagnose, treat and monitor patients across all major disease pathways including neurology, cardiology and oncology. Our customers include Radiology and Nuclear Medicine departments and pharmaceutical companies.

Decades of experience delivering imaging agents globally

We have seven GE HealthCare-owned, vertically integrated plants, all current good manufacturing process (cGMP)- accredited, producing active ingredient through to finished product. Over the past decade we have invested almost $400 million to increase manufacturing capacity to address growing global demand.

Download our key locations map

Innovating for the future

We have multiple programmes in pre-clinical and clinical phases across contrast media and radiopharma with research and development hubs located in:
• Amersham, UK
• Oslo, Norway
• Shanghai, China
• Toulouse, France
• Japan

We also partner with top academic centres in the US, Europe, and Asia.